KAMN yields 1.74% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, KAMN + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KAMN + JNJ for your $10,000?
Kaman Corporation, together with its subsidiaries, operates in the aerospace, defense, medical, and industrial markets. The company operates through three segments: Engineered Products, Precision Products, and Structures. The Engineered Products segment produces and markets aircraft bearings and components; super precision miniature ball bearings; and spring energized seals, springs, and contacts. The Precision Products segment provides safe and arming solutions for missile and bomb systems for the U.S. and allied militaries; undertakes subcontract helicopter works; restores, modifies, and supports its SH-2G Super Seasprite maritime helicopters; and manufactures and supports heavy lift K-MAX manned helicopter, the K-MAX TITAN unmanned aerial system, and the KARGO UAV unmanned aerial system. The Structures segment offers metallic and composite aero structures for commercial, military, and general aviation fixed and rotary wing aircrafts; and medical imaging solutions. The company operates in North America, Europe, the Middle East, Asia, Oceania, and internationally. Kaman Corporation was incorporated in 1945 and is headquartered in Bloomfield, Connecticut.
Full KAMN Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.